Application 215155
- Type
- ANDA
- Sponsor
- ALKEM LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | SITAGLIPTIN PHOSPHATE | SITAGLIPTIN PHOSPHATE | TABLET;ORAL | EQ 50MG BASE | No | No |
| 003 | SITAGLIPTIN PHOSPHATE | SITAGLIPTIN PHOSPHATE | TABLET;ORAL | EQ 100MG BASE | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sitagliptin Phosphate | SITAGLIPTIN PHOSPHATE | Sandoz Inc | cebc8388-c9db-4e27-8d6b-0d9bdc9d766d | 2026-05-10 | Warnings, Adverse reactions | Sitagliptin Phosphate SITAGLIPTIN PHOSPHATE |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85403 | ORIG | 2026-03-19 |